样本类型对儿科先天性听力损失患者遗传测试完成的影响
Brittany Adams1, Lauren Lichten2, Aaliyah Heyward3
1Winship Cancer Institute, Emory Healthcare, 6335 Hospital Parkway Ste 109, Johns Creek, GA, 30097, USA.
Journal of community genetics
|January 23, 2026
概括
针对儿科听力损失的基因检测显示,无论是采用血液抽取还是口腔扫描,完成率都相似. 这表明,除了样本类型之外的因素影响了儿童完成测试.
科学领域:
- 遗传学 遗传学 是一个
- 儿科 儿科 儿科
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 先天性儿科听力损失具有显著的遗传成分,影响约60%的病例.
- 针对儿科听力损失的基因检测 (GT) 可能面临后勤挑战,包括采集血液样本.
- 非综合征感应神经听力损失是一种常见的儿科听力损失形式,需要准确的诊断.
研究的目的:
- 确定基因检测样本采集方法是否会影响儿科患者的完成率.
- 为了比较通过抽血和口腔抽样完成基因测试的百分比.
- 探索影响先天性听力损失遗传测试完成的因素.
主要方法:
- 在第三级儿科耳鼻喉科诊所进行了回顾性图表审查.
- 两个队列的比较:抽血 (2022年5月至2023年4月) 和口腔抽样 (2023年6月至2024年5月).
- 主要终点:完成基因测试;次要数据:人口统计,周转时间和结果.
主要成果:
- 抽血和口腔抽样队伍都实现了高基因测试完成率,约93%左右.
- 与血液样本 (79/227) 相比,通过口腔抹布 (148/227) 订购的基因测试显著更多.
- 两种样本采集方法在遗传测试结果中没有发现显著差异.
结论:
- 样品类型 (血液与口腔抹布) 似乎不是在儿科听力损失中遗传测试完成的唯一决定因素.
- 完成基因测试的障碍可能是多因素的,涉及复杂的家庭决策过程.
- 其他采样方法,如口腔扫描,可能会增加测试订单,但与血液抽取相比,不会显著改变完成率.
相关概念视频
02:18Types of Genetic Transfer Between Organisms
30.6K
Genetic transfer occurs when genetic information is passed from one organism to another. It occurs via two mechanisms: vertical gene transfer and horizontal gene transfer. Vertical gene transfer occurs when genetic information is transferred from one generation to the next, which happens much more frequently than horizontal gene transfer. Both sexual and asexual reproduction are forms of vertical gene transfer, where one or more organisms pass some or all of their genome onto their progeny.
30.6K
02:18Types of Genetic Transfer Between Organisms
6.3K
6.3K
01:31Hearing
56.8K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
56.8K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
276
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
200
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200